Rennova Health, Inc. - Quarter Report: 2006 June (Form 10-Q)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 10-Q
(Mark
One)
|
||
x
|
QUARTERLY REPORT PURSUANT TO SECTION
13 OR
15(d)
OF THE SECURITIES EXCHANGE ACT OF
1934
|
For
the quarterly period ended June 30, 2006
or
o
|
TRANSITION REPORT PURSUANT TO SECTION
13 OR
15(d)
OF THE SECURITIES EXCHANGE ACT OF
1934
|
Commission
File Number: 0-26824
TEGAL
CORPORATION
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
|
68-0370244
|
|
(State
or other jurisdiction of
|
(I.R.S.
Employer Identification No.)
|
|
incorporation
or organization)
|
2201
South McDowell Blvd.
Petaluma,
California 94954
|
||
(Address
of Principal Executive Offices)
|
||
Telephone
Number (707) 763-5600
|
||
(Registrant’s
Telephone Number, Including Area Code)
|
Indicate
by check mark whether the registrant: (1) has filed all reports required to
be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the
preceding 12 months (or for such shorter period that the registrant was required
to file reports) and (2) has been subject to such filing requirements for the
past 90 days. Yes x
No o
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, or a non-accelerated filer. (See definition of “accelerated
filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.) (Check
One):
Large
accelerated filer o Accelerated
filer o Non-accelerated
filer x
As
of
August 11, 2006 there were
7,038,957
shares
of our common stock outstanding. The
number of shares outstanding reflects a 1 to 12 reverse stock split effected
by
the Registrant on July 25, 2006.
1
TEGAL
CORPORATION AND SUBSIDIARIES
INDEX
|
|
Page
|
|||
PART
I. FINANCIAL INFORMATION
|
|||||
ITEM
1.
|
CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
|
||||
Condensed
Consolidated Balance Sheets as of June 30, 2006 and March 31,
2006
|
3
|
||||
Condensed
Consolidated Statement of Operations for the three months ended June
30,
2006 and June 30, 2005
|
4
|
||||
Condensed
Consolidated Statement of Cash Flows as of June 30, 2006 and June
30,
2005
|
5
|
||||
Notes
to Condensed Consolidated Financial Statements
|
6
|
||||
ITEM
2.
|
MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
|
||||
OF
OPERATIONS
|
12
|
||||
ITEM
3.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
18
|
|||
ITEM
4.
|
CONTROLS
AND PROCEDURES
|
19
|
|||
PART
II. OTHER INFORMATION
|
|||||
ITEM
1.
|
LEGAL
PROCEEDINGS
|
19
|
|||
ITEM
1A.
|
RISK
FACTORS
|
20
|
|||
ITEM
6.
|
EXHIBITS
|
24
|
|||
SIGNATURES
|
24
|
2
PART
I — FINANCIAL INFORMATION
Item
1. Condensed
Consolidated Financial Statements
TEGAL
CORPORATION AND SUBSIDIARIES
CONDENSED
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In
thousands, except share data)
|
June
30,
2006
|
March
31,
2006
|
|||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
12,640
|
$
|
13,787
|
|||
Accounts
receivable, net of allowances for sales returns and doubtful accounts
of
$356 and $205 at
June
30, 2006, and March 31, 2006, respectively
|
6,344
|
5,265
|
|||||
Inventories
|
6,974
|
7,700
|
|||||
Prepaid
expenses and other current assets
|
1,284
|
1,270
|
|||||
Total
current assets
|
27,242
|
28,022
|
|||||
Property
and equipment, net
|
1,692
|
1,849
|
|||||
Intangible
assets, net
|
1,396
|
1,474
|
|||||
Other
assets
|
148
|
146
|
|||||
Total
assets
|
$
|
30,478
|
$
|
31,491
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Notes
payable and bank lines of credit
|
$
|
107
|
$
|
27
|
|||
Accounts
payable
|
2,708
|
2,458
|
|||||
Accrued
product warranty
|
668
|
506
|
|||||
Deferred
revenue
|
564
|
477
|
|||||
Accrued
expenses and other current liabilities
|
2,264
|
1,975
|
|||||
Total
current liabilities
|
6,311
|
5,443
|
|||||
Long-term
portion of capital lease obligations
|
—
|
2
|
|||||
Other
long term obligations
|
—
|
6
|
|||||
Total
long term liabilities
|
8
|
||||||
Total
liabilities
|
$
|
6,311
|
$
|
5,451
|
|||
Stockholders’
equity:
|
|||||||
Preferred
stock; $ 0.01 par value;
5,000,000
shares authorized; none issued and outstanding
|
$
|
—
|
$
|
—
|
|||
Common
stock; $ 0.01 par value; 200,000,000
shares authorized;
7,039,173 and 7,021,088
shares issued
|
|||||||
and
outstanding at June 30, 2006 and March 31, 2006
respectively
|
844
|
842
|
|||||
Restricted
Share Units
|
840
|
1,034
|
|||||
Deferred
Compensation
|
(224
|
)
|
(224
|
)
|
|||
Additional
paid-in capital
|
119,471
|
119,010
|
|||||
Accumulated
other comprehensive income
|
192
|
532
|
|||||
Accumulated
deficit
|
(96,956
|
)
|
(95,154
|
)
|
|||
Total
stockholders’ equity
|
24,167
|
26,040
|
|||||
Total
liabilities and stockholders’ equity
|
$
|
30,478
|
$
|
31,491
|
See
accompanying notes.
3
TEGAL
CORPORATION AND SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In
thousands, except per share data)
|
Three
Months Ended
June
30,
|
||||||
|
2006
|
2005
|
|||||
Revenue
|
$
|
6,576
|
$
|
3,052
|
|||
Cost
of sales
|
4,078
|
2,377
|
|||||
Gross
profit (loss)
|
2,498
|
675
|
|||||
Operating
expenses:
|
|||||||
Research
and development
|
996
|
1,176
|
|||||
Sales
and marketing
|
1,044
|
644
|
|||||
General
and administrative
|
2,302
|
1,240
|
|||||
Total
operating expenses
|
4,342
|
3,060
|
|||||
Operating
loss
|
(1,844
|
)
|
(2,385
|
)
|
|||
Other
income (expense), net
|
42
|
(122
|
)
|
||||
Net
loss
|
$
|
(1,802
|
)
|
$
|
(2,507
|
)
|
|
Net
loss per share, basic and diluted
|
$
|
(0.26
|
)
|
$
|
(0.57
|
)
|
|
Shares
used in per share computation:
|
|||||||
Basic
|
7,023
|
4,409
|
|||||
Diluted
|
7,023
|
4,409
|
Note:
Shares used in per share computation for Basic and Diluted reflect a 1 to12
reverse stock split
effected
by the Company on July 25, 2006
See
accompanying notes.
4
TEGAL
CORPORATION AND SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In
thousands)
Three
Months Ended
June
30,
|
|||||||
|
2006
|
2005
|
|||||
Cash
flows from operating activities:
|
|||||||
Net
loss
|
$
|
(1,802
|
)
|
$
|
(2,507
|
)
|
|
Adjustments
to reconcile net loss to cash used in operating
activities:
|
|||||||
Depreciation
and amortization
|
232
|
339
|
|||||
Stock
Compensation Expense
|
230
|
||||||
Fair
value of warrants issued for services rendered
|
26
|
84
|
|||||
Provision
for doubtful accounts and sales return allowances
|
152
|
(3
|
)
|
||||
Excess
and obsolete inventory provision
|
(2,089
|
)
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Receivables
|
(1,017
|
)
|
(778
|
)
|
|||
Inventories
|
2,324
|
(733
|
)
|
||||
Prepaid
expenses and other assets
|
(13
|
)
|
(46
|
)
|
|||
Accounts
payable
|
211
|
53
|
|||||
Accrued
expenses and other liabilities
|
224
|
(392
|
)
|
||||
Accrued
product warranty
|
112
|
(5
|
)
|
||||
Deferred
revenue
|
87
|
156
|
|||||
Net
cash used in operating activities
|
$
|
(1,322
|
)
|
$
|
(3,832
|
)
|
|
Cash
flows used in investing activities:
|
|||||||
Purchases
of property and equipment
|
$
|
(20
|
)
|
$
|
(84
|
)
|
|
Loss
on disposal of property and equipment
|
23
|
||||||
Net
cash used in investing activities:
|
3
|
(84
|
)
|
||||
Cash
flows provided by financing activities:
|
|||||||
Net
proceeds from issuance of common stock
|
4
|
126
|
|||||
Borrowings
under lines of credit
|
94
|
34
|
|||||
Repayment
of borrowings under lines of credit
|
(110
|
)
|
|||||
Proceeds
from and (payments on) capital lease financing
|
(2
|
)
|
(3
|
)
|
|||
Net
cash provided by financing activities
|
96
|
47
|
|||||
Effect
of exchange rates on cash and cash equivalents
|
76
|
(26
|
)
|
||||
Net
increase (decrease) in cash and cash equivalents
|
(1,147
|
)
|
(3,895
|
)
|
|||
Cash
and cash equivalents at beginning of period
|
13,787
|
7,093
|
|||||
Cash
and cash equivalents at end of period
|
$
|
12,640
|
$
|
3,198
|
See
accompanying notes.
5
TEGAL
CORPORATION AND SUBSIDIARIES
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(All
amounts in thousands, except share data)
1.
Basis of Presentation:
In
the
opinion of management, the unaudited condensed consolidated interim financial
statements have been prepared on the same basis as the March 31, 2006 audited
consolidated financial statements and include all adjustments, consisting only
of normal recurring adjustments, necessary to fairly state the information
set
forth herein. The statements have been prepared in accordance with the
regulations of the Securities and Exchange Commission (the “SEC”), but omit
certain information and footnote disclosures necessary to present the statements
in accordance with generally accepted accounting principles. These interim
financial statements should be read in conjunction with the consolidated
financial statements and footnotes included in the Company’s Annual Report on
Form 10-K for the fiscal year ended March 31, 2006. The results of operations
for the three months ended June 30, 2006 are not necessarily indicative of
results to be expected for the entire year.
The
condensed consolidated financial statements contemplate the realization of
assets and the satisfaction of liabilities in the normal course of business.
The
Company incurred net losses of $1,802
and
$2,507 for the periods ended June 30, 2006 and 2005, respectively. The Company
generated negative cash flows from operations of $1,322 and $3,832 for the
period ended June 30, 2006 and 2005, respectively. During the Fiscal Year 2006
the Company raised a net of $18,161 through a private investment placement
of
equity. Management believes that these proceeds, combined with projected sales,
consolidation of certain operations and continued cost containment will be
adequate to fund operations through fiscal 2007. However, projected sales may
not materialize and unforeseen costs may be incurred.
If
the
projected sales do not materialize, the Company’s ability to achieve its
intended business objectives may be adversely affected. The consolidated
financial statements do not include any adjustments relating to the
recoverability and classification of recorded assets or the amount or
classification of liabilities or any other adjustments that might be necessary
should the Company be unable to continue as a going concern.
On
July
21, 2006, Tegal Corporation filed with the Secretary of State of the State
of
Delaware a Certificate of Amendment to the Company’s Certificate of
Incorporation to affect a 1-for-12 reverse stock split of the Company’s common.
The condensed consolidated financial statements for current and prior periods
have been adjusted to reflect the change in number of shares.
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to significant concentrations
of credit risk consist primarily of temporary cash investments and accounts
receivable. Substantially all of the Company’s temporary investments are
invested in money market funds. The Company’s accounts receivable are derived
primarily from sales to customers located in the U.S., Europe and Asia. The
Company performs ongoing credit evaluations of its customers and generally
requires no collateral. The Company maintains reserves for potential credit
losses. Write-offs during the periods presented have been insignificant.
During
the three months ending June 30, 2006, three (3) customers
(ST Microelectronics, FlipChip, and RF Micro Devices) accounted for
83%
of total
revenues. During the three months ending June 30, 2005, three (3) customers
accounted
for 63% of total revenues.
During
the three months ended June 30, 2006 and June 30, 2005, three customers
accounted for approximately 80% and 70%, respectively of the accounts receivable
balance
Stock
Based Compensation
Adoption
of SFAS 123R
The
Company has adopted several stock plans that provide equity instruments to
our
employees and non-employee directors. Our plans include incentive and
non-statutory stock options and restricted stock awards. Stock options generally
vest ratably over a four-year period on the anniversary date of the grant,
and
expire ten years after the grant date. Restricted stock awards generally vest
on
the achievement of specific performance targets. The Company also has employee
stock purchase plans that allow qualified employees to purchase Company shares
at 85% of the fair market value on specified dates.
Prior
to
April 1, 2006 we accounted for these stock-based employee compensation plans
under the measurement and recognition provisions of Accounting Principles Board
Opinion No. 25, “Accounting for Stock Issued to Employees” or APB 25, and
related Interpretations, as permitted by SFAS No. 123, “Accounting for Stock
Based Compensation,” or SFAS 123. With the exception of grants of restricted
stock awards, we generally recorded no stock-based compensation expense during
periods prior to April 1, 2006 as all stock-based grants had exercise prices
equal to the fair market value of our common stock on the date of grant. We
also
recorded no compensation expense in connection with our employee stock purchase
plans as they qualified as non-compensatory plans following the guidance
provided by APB 25. In accordance with SFAS 123 and SFAS 148 “Accounting for
Stock-Based Compensation-Transition and Disclosure,” later in this Note we
disclose our net loss and net loss per share for the quarter ended June 30,
2005
as if we had applied the fair value-based method in measuring compensation
expense for our stock-based compensation plans.
6
Effective
April 1, 2006, we adopted the fair value recognition provisions of SFAS No.
123R
using the modified prospective transition method. Under that transition method,
compensation expense that we recognized for the three months ended June 30,
2006
included: (a) compensation expense for all share-based payments granted prior
to
but not yet vested as of April 1, 2006, based on the grant date fair value
estimated in accordance with the original provisions of SFAS 123, and (b)
compensation expense for all share-based payments granted or modified on or
after April 1, 2006, based on the grant date fair value estimated in accordance
with the provisions of SFAS 123R. Compensation expense is recognized only for
those awards that are expected to vest, whereas prior to the adoption of SFAS
123R, we recognized forfeitures as they occurred. In addition, we elected the
straight-line attribution method as our accounting policy for recognizing
stock-based compensation expense for all awards that are granted on or after
April 1, 2006. Results in prior periods have not been restated.
Total
stock compensation expense for the period ended June 30, 2006 was $230. The
total compensation expense related to nonvested awards not yet recognized is
$1,019. The weighted average period for which it is expected to be recognized
is
2.3 years.
Had
the
Company adopted SFAS No 123R during the fiscal year ended March 31, 2006,
compensation expense of approximately $1,770 would have been recognized in
the
consolidated statements of operations for the year ended March 31, 2006.
The
following assumptions are included in the estimated grant date fair value
calculations for the Company’s stock option awards and Employee Qualified Stock
Purchase Plan (“ESPP”):
Three
Months Ended
June
30,
|
|||||||
2006
|
2005
|
||||||
Expected
life (years):
|
|||||||
Stock
options
|
4.0
|
4.0
|
|||||
ESPP
|
0.5
|
0.5
|
|||||
Volatility:
|
|||||||
Stock
options
|
82.40
|
%
|
71.00
|
%
|
|||
ESPP
|
82.40
|
%
|
71.00
|
%
|
|||
Risk-free
interest rate
|
5.25
|
%
|
3.21
|
%
|
|||
Dividend
yield
|
0.00
|
%
|
0.00
|
%
|
During
the three months ended June 30, 2006, there were no stock option
grants.
The
following table illustrates on a post reverse stock split basis, the effect
on
net income (loss) and net income (loss) per share if the Company had applied
the
fair value recognition provisions of SFAS No. 123R to stock-based compensation
(in thousands, except per share data):
Three
Months Ended
June
30, 2005
|
||||
Net
loss as reported
|
$
|
(2,507
|
)
|
|
Add:
Stock-based employee compensation expense included in reported net
loss
|
||||
Deduct:
Total stock-based employee compensation expense determined under
fair
value method for all awards
|
(546
|
)
|
||
Proforma
net loss
|
$
|
(3,053
|
)
|
|
Basic
net loss per share:
|
||||
As
reported
|
$
|
(
0.57
|
)
|
|
Proforma
|
$
|
(0.69
|
)
|
7
The
disclosure provisions of SFAS No. 123R and SFAS No. 148 require judgments by
management as to the estimated lives of the outstanding options. Management
has
based the estimated life of the options on historical option exercise patterns.
If the estimated life of the options increases, the valuation of the options
will increase as well.
Stock
Options & Warrants
A
summary
of stock option and warrant activity during the quarter ended June 30, 2006
is
as follows:
Shares
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Contractual
Term
(in Years)
|
Aggregate
Intrinsic Value |
||||||||||
BEGINNING
OUTSTANDING
|
2,304,522
|
$
|
13.70
|
||||||||||
GRANTED
|
0
|
||||||||||||
EXERCISED
|
0
|
||||||||||||
CANCELLED:
|
|||||||||||||
Forfeited
|
(260
|
)
|
$
|
15.60
|
|||||||||
Expired
|
(23,945
|
)
|
$
|
29.10
|
|||||||||
Total
|
(24,206
|
)
|
$
|
28.96
|
|||||||||
ENDING
OUTSTANDING
|
2,280,317
|
$
|
13.54
|
5.12
|
5,884
|
||||||||
ENDING
VESTED + EXPECTED TO VEST
|
2,260,139
|
$
|
13.56
|
0.10
|
5,884
|
||||||||
ENDING
EXERCISABLE
|
2,081,878
|
$
|
13.76
|
4.84
|
5,884
|
The
aggregate intrinsic value of options and warrants outstanding at June 30, 2006
is calculated as the difference between the exercise price of the underlying
options and the market price of our common stock for the 16,344 warrants that
had an exercise price that was lower than the market price of our common stock
as of June 30, 2006.
The
following table summarizes information with respect to stock options and
warrants outstanding as of June 30, 2006:
Range
of
Exercise Prices |
Number
Outstanding
As
of
June 30, 2006 |
Weighted
Average
Remaining
Contractual
Term
(in Years)
|
Weighted
Average
Exercise Price |
Number
Exercisable
As
of
June 30, 2006 |
|||||||||||||
$ |
4.20
|
$
|
8.28
|
353,839
|
7.09
|
$
|
6.99
|
244,152
|
|||||||||
9.60
|
9.96
|
13,554
|
3.82
|
9.74
|
13,207
|
||||||||||||
12.00
|
12.00
|
1,285,000
|
4.18
|
12.00
|
1,285,000
|
||||||||||||
12.36
|
12.96
|
243,191
|
7.52
|
12.43
|
194,162
|
||||||||||||
13.20
|
25.68
|
245,833
|
6.82
|
16.65
|
206,458
|
||||||||||||
27.00
|
82.56
|
130,150
|
1.61
|
37.61
|
130,150
|
||||||||||||
92.26
|
92.26
|
417
|
3.69
|
92.26
|
417
|
||||||||||||
92.52
|
92.52
|
4,167
|
3.63
|
92.52
|
4,167
|
||||||||||||
99.00
|
99.00
|
2,500
|
3.74
|
99.00
|
2,500
|
||||||||||||
105.00
|
105.00
|
1,667
|
2.48
|
105.00
|
1,667
|
||||||||||||
$ |
4.20
|
$
|
105.00
|
2,280,317
|
5.12
|
$
|
46.71
|
2,081,878
|
8
Restricted
Stock Units
The
following table summarizes our restricted stock award activity for the three
ended June 30, 2006:
Number
of Shares
|
Weighted
Average Grant Date Fair
Value
|
||||||
Balance,
March 31, 2006
|
79,167
|
$
|
10.20
|
||||
Granted
|
—
|
—
|
|||||
Vested
|
—
|
—
|
|||||
Forfeited
|
—
|
—
|
|||||
Released
|
16,667
|
11.64
|
|||||
Balance,
June 30, 2006
|
62,500
|
$
|
9.82
|
Unvested
restricted stock at June 30, 2006
As
of
June 30, 2006, there was $224 of total unrecognized compensation cost related
to
restricted stock which is expected to be recognized during the current fiscal
year. As of June 30, 2006, there were a total
of
54,167 restricted
shares subject to performance conditions that will result in forfeiture if
the
conditions are not realized.
2.
Inventories:
Inventories
are stated at the lower of cost or market, reduced by provisions for excess
and
obsolescence. Cost is computed using standard cost, which approximates actual
cost on a first-in, first-out basis and includes material, labor and
manufacturing overhead costs. We estimate the effects of excess and obsolescence
on the carrying values of our inventories based upon estimates of future demand
and market conditions. We establish provisions for related inventories in excess
of production demand. Should actual production demand differ from our estimates,
additional inventory write-downs may be required, as was the case in the forth
quarter of fiscal 2005. Any excess and obsolete provision is released only
if
and when the related inventory is sold or scrapped. During the three months
ending June 30, 2006 and June 30, 2005, the Company sold or
scrapped previously reserved inventory of $2,088 and $155 respectively. The
inventory provision at June 30, 2006 and June 30, 2005 was $5,047 and $8,126,
respectively.
Inventories
for the periods presented consisted of:
June
30
2006
|
March
31
2006
|
||||||
Raw
materials
|
$
|
586
|
$
|
1,692
|
|||
Work
in progress
|
4,435
|
4,173
|
|||||
Finished
goods and spares
|
1,953
|
1,835
|
|||||
$
|
6,974
|
$
|
7,700
|
We
periodically analyze any systems that are in finished goods inventory to
determine if they are suitable for current customer requirements. At the present
time, our policy is that, if after approximately 18 months, we determine that
a
sale will not take place within the next 12 months and the system would be
useable for customer demonstrations or training, it is transferred to fixed
assets. Otherwise, it is expensed.
3.
Product Warranty:
The
Company provides warranty on all system sales based on the estimated cost of
product warranties at the time revenue is recognized. The warranty obligation
is
affected by product failure rates, material usage rates, and the efficiency
by
which the product failure is corrected. Should actual product failure rates,
material usage rates and labor efficiencies differ from estimates, revisions
to
the estimated warranty liability may be required.
9
Warranty
activity for the three-month periods ended June 30, 2006 and 2005
was:
Warranty
Activity for the
Three Months Ended June
30,
|
|||||||
2006
|
2005
|
||||||
Balance
at the beginning of the period
|
$
|
506
|
$
|
252
|
|||
Additional
warranty accruals for warranties issued during the period
|
384
|
45
|
|||||
Accruals
related to pre-existing warranties
|
(62
|
)
|
|||||
Less
settlements made during the period
|
(160
|
)
|
(59
|
)
|
|||
Balance
at the end of the period
|
$
|
668
|
$
|
238
|
Certain
of the Company's sales contracts include provisions under which customers would
be indemnified by the Company in the event of, among other things, a third-party
claim against the customer for intellectual property rights infringement related
to the Company's products. There are no limitations on the maximum potential
future payments under these guarantees. The Company has accrued no amounts
in
relation to these provisions as no such claims have been made and the Company
believes it has valid, enforceable rights to the intellectual property embedded
in its products.
4.
Net Loss Per Common Share:
Basic
net
loss per common share is computed using the weighted-average number of shares
of
common stock outstanding.
The
following table represents the calculation of basic and diluted net loss per
common share (in thousands, except per share data):
Three
Months Ended
June
30,
|
|||||||
2006
|
2005
|
||||||
Net
loss applicable to common stockholders
|
$
|
(1,802
|
)
|
$
|
(2,507
|
)
|
|
Basic
and diluted:
|
|||||||
Weighted-average
common shares outstanding
(adjusted to reflect 1 to 12 reverse stock split)
|
7,023
|
4,409
|
|||||
Less
weighted-average common shares subject to repurchase…
|
0
|
0
|
|||||
Weighted-average
common shares used in computing basic and diluted net loss per common
share …………………………
|
7,023
|
4,409
|
|||||
Basic
and diluted net loss per common
share
…………………….
|
$
|
(0.26
|
)
|
$
|
(0.57
|
)
|
Outstanding
options, warrants and restricted stock equivalent of 2,342,817
and
9,749
shares
of common stock at a weighted-average exercise price of $13.54 and $6.84 per
share on June 30, 2006 and 2005 respectively, were not included in the
computation of diluted net loss per common share for the periods presented
as a
result of their anti-dilutive effect. Such securities could potentially dilute
earnings per share in future periods.
5.
Stock-Based Transactions:
Issuance
of Warrants to Consultants
The
Company is party to a contract with certain consultants pursuant to which the
Company will issue warrants on a monthly basis in lieu of cash payments through
August 2006, depending upon the continuation of the contract and the achievement
of certain performance goals. The maximum number of warrants to be issued under
these agreements is
82,500
shares.
During
the three months ended June 30, 2006 and June 30, 2005 6,667 and 7,083,
respectively, were issued valued at $32 and $84, respectively, using the Black
Scholes model with an exercise price at the market value on the day of the
grant. The
life
of the warrants is five and seven years with an interest rate of 2.225% and
volatility of 118% and 115% respectively. None of these warrants have been
exercised as of June 30, 2006.
10
6.
Lines of Credit:
As
of
June 30, 2006, our Japanese subsidiary had $107 outstanding under its lines
of
credit which is collateralized by Japanese customer promissory notes held by
such subsidiary in advance of payment on customers’ accounts receivable. The two
credit lines have a total borrowing capacity of 150 million yen (approximately
$1,304 at exchange rates prevailing on June 30, 2006), which are secured by
Japanese customer promissory notes held by such subsidiary in advance of payment
on customers’ accounts receivable. The two Japanese bank lines bear interest at
Japanese prime (1.375% as of June 30, 2006) plus 0.875%. At
of
June 30, 2005, the Company’s Japanese subsidiary had borrowed 3.9 million Yen
(approximately $35 at exchange rates prevailing on June 30, 2005) under its
Japanese bank line of credit. The credit line has a total borrowing capacity
of
150 million Yen (approximately $1,351 at exchange rates prevailing on June
30,
2005).
Notes
payable as of June 30, 2006 consisted of capital lease obligations on fixed
assets totaling $11.
7.
Legal Proceedings
Sputtered
Films, Inc. v. Advanced Modular Sputtering, et al., filed in Santa Barbara
County Superior Court.
On
December 22, 2003, Sputtered Films, Inc. ("SFI"), a wholly owned subsidiary
of
the Company, filed an action against two former employees, Sergey Mishin and
Rose Stuart-Curran, and a company they formed after leaving their employment
with SFI named Advanced Modular Sputtering, Inc. ("AMS"). Sergey Mishin and
Rose
Stuart-Curran had each signed confidentiality and non-disclosure agreements
regarding information obtained while employed by SFI. The action contains causes
of action for specific performance, breach of contract, breach of the covenant
of good faith and fair dealing, misappropriation of trade secrets, unfair
competition, unfair business practices, and interference with prospective
economic advantage, conversion, unjust enrichment, and declaratory relief.
These
claims arise out of information SFI received evidencing that AMS possessed
and
used SFI's confidential, proprietary and trade secret drawings, specifications
and technology to manufacture the sputtering tool marketed by AMS.
During
2004 and 2005, this litigation was largely stalled while AMS and Agilent
Technologies, Inc. contested SFI's right to conduct discovery. This dispute
was
resolved in late 2005 when the California Court of Appeal affirmed SFI's trade
secret identification as statutorily sufficient. On November 18, 2005, SFI
requested leave to add Agilent Technologies, Inc. ("Agilent") as a defendant
based on evidence that Agilent and AMS co-developed the machines which SFI
contends were built using SFI proprietary information. The Court granted SFI's
request and Agilent was served as a Doe defendant on December 12, 2005. In
early
December, SFI learned that Agilent transferred its Semiconductor Products Group
to a number of Avago entities effective December 1, 2005, and accordingly SFI
sought and received court approval to add Avago Technologies U.S., Inc. and
Avago Technologies Wireless (U.S.A.) Manufacturing, Inc (collectively the "Avago
Entities") as defendant in this action. On April 25, 2006, the Avago Entities
filed a Cross-Complaint against SFI and Tegal Corporation alleging causes of
action for breach of contract, trade secret misappropriation, unfair
competition, conversion, unjust enrichment and declaratory relief. The
Cross-Complaint alleges on information and belief that SFI misused information
obtained from Hewlett-Packard in connection with Hewlett-Packard's request
to
purchase SFI machines or to upgrade SFI machines Hewlett-Packard already owned.
SFI and Tegal Corporation intend to vigorously contest all such allegations.
Trial is currently set for November 7, 2006, although the Court has indicated
that it may bifurcate the Avago Entities' cross-claims. The Court severed from
SFI's action the Cross-Complaint filed by the Avago Entities, and all matters
regarding the Avago Cross-Complaint, including discovery, are stayed until
after
completion of the trial on SFI's Complaint.
8.
Geographical Information
Tegal
operates in one segment for the manufacture, marketing and servicing of
integrated circuit fabrication equipment. In accordance with SFAS No. 131 (SFAS
131) “Disclosures About Segments of an Enterprise and Related Information,”
Tegal’s chief operating decision-maker has been identified as the President and
Chief Executive Officer, who reviews operating results to make decisions about
allocating resources and assessing performance for the entire company. All
material operating units qualify for aggregation under SFAS 131 due to their
identical customer base and similarities in: economic characteristics; nature
of
products and services; and procurement, manufacturing and distribution
processes. Since Tegal operates in one segment and in one group of similar
products and services, all financial segment and product line information
required by SFAS 131 can be found in the consolidated financial
statements.
For
geographical reporting, revenues are attributed to the geographic location
in
which the customers’ facilities are located. Long-lived assets consist primarily
of property, plant and equipment, and are attributed to the geographic location
in which they are located. Net sales and long-lived assets by geographic region
were as follows:
Revenue
for the
Three
Months
Ended June 30, |
|||||||
2006
|
2005
|
||||||
Sales
to customers located in:
|
|||||||
United
States
|
$
|
5,044
|
$
|
327
|
|||
Asia,
excluding Japan
|
179
|
140
|
|||||
Japan
|
524
|
578
|
|||||
Europe
|
829
|
2,007
|
|||||
Total
sales
|
$
|
6,576
|
$
|
3,052
|
Long-lived
Assets
as of June 30, |
|||||||
|
2006
|
2005
|
|||||
Long-lived
assets at period-end:
|
|||||||
United
States
|
$
|
4,336
|
$
|
4,857
|
|||
Europe
|
14
|
5
|
|||||
Japan
|
10
|
19
|
|||||
Asia,
excluding Japan
|
2
|
2
|
|||||
Total
long-lived assets
|
$
|
4,362
|
$
|
4,883
|
11
9.
Comprehensive Income (Loss):
The
components of comprehensive loss for the three months ended June 30, 2006 and
2005 are as follows:
|
Three
Months Ended
June
30,
|
||||||
|
2006
|
2005
|
|||||
Net
loss
|
$
|
(1,802
|
)
|
$
|
(2,507
|
)
|
|
Foreign
currency translation adjustment
|
(331
|
)
|
174
|
||||
Total
comprehensive loss
|
$
|
(2,133
|
)
|
$
|
(2,333
|
)
|
10. Subsequent
Events
Reverse
Stock Split
On
July
21, 2006, Tegal Corporation filed with the Secretary of State of the State
of
Delaware a Certificate of Amendment to the Company’s Certificate of
Incorporation to effect a 1-for-12 reverse stock split of the Company’s common
stock (the “Reverse Stock Split”). The Reverse Stock Split received the required
approval of the Company’s stockholders at the Company’s annual meeting held on
July 21, 2006. The reverse stock split took effect before trading began on
Tuesday, July 25, 2006, at which time the symbol will changed to TGALD. The
symbol will return to the normal TGAL at the open of the market on August 22,
2006. In lieu of any fractional shares to which a holder of common stock would
otherwise be entitled as a result of the Reverse Stock Split, the Company will
pay cash equal to such fraction multiplied by $4.68, which is the average of
the
high and low trading prices of our common stock on the Nasdaq Capital Market
during regular trading hours for the five trading day period ending on July
21,
2006.
On
August
8, 2006, the Company received notice from the Nasdaq Stock Market that it had
regained compliance with its listing requirements.
Item
2. Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
Special
Note Regarding Forward Looking Statements
Information
herein contains “forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995, which can be identified by the use
of
forward-looking terminology such as “may,” “will,” “expect,” “anticipate,”
“estimate,” or “continue” or the negative thereof or other variations thereon or
comparable terminology or which constitute projected financial information.
The
forward-looking statements relate to the near-term semiconductor capital
equipment industry outlook, demand for our products, our quarterly revenue
and
earnings prospects for the near-term future and other matters contained herein.
Such statements are based on current expectations and beliefs and involve a
number of uncertainties and risks that could cause the actual results to differ
materially from those projected. Such uncertainties and risks include, but
are
not limited to, cyclicality of the semiconductor industry, impediments to
customer acceptance of our products, fluctuations in quarterly operating
results, competitive pricing pressures, the introduction of competitor products
having technological and/or pricing advantages, product volume and mix and
other
risks detailed from time to time in our SEC reports, including in the section
entitled “Risk Factors” elsewhere in this report. For further information, refer
to the business description and risk factors described below. All
forward-looking statements are expressly qualified in their entirety by the
cautionary statements in this paragraph.
Tegal
designs, manufactures, markets and services plasma etch and deposition systems
that enable the production of integrated circuits (“ICs”), memory and related
microelectronics devices used in personal computers, wireless voice and data
telecommunications, contact-less transaction devices, radio frequency
identification devices (“RFID’s”), smart cards, data storage and micro-level
actuators. Etching and deposition constitute two of the principal IC and related
device production process steps and each must be performed numerous times in
the
production of such devices.
Semiconductor
Industry Background
Over
the
past twenty years, the semiconductor industry has experienced significant
growth. This growth has resulted from the increasing demand for ICs from
traditional IC markets, such as personal computers, telecommunications, consumer
electronics, automotive electronics and office equipment, as well as developing
markets, such as wireless communications, multimedia and portable and network
computing. As a result of this increased demand, semiconductor device
manufacturers have periodically expended significant amounts of capital to
build
new semiconductor fabrication facilities (“fabs”) and to expand existing fabs.
More recently, growth has slowed, and there are signs that the industry is
beginning to mature. While unit demand for semiconductor devices continue to
rise, the average selling prices of chips continue to decline. There is growing
pressure on semiconductor device manufacturers to reduce manufacturing costs
while increasing the value of their products. The semiconductor industry has
also been historically cyclical, with periods of rapid expansion followed by
periods of over-capacity.
12
Growth
in
the semiconductor industry has been driven, in large part, by advances in
semiconductor performance at a decreasing cost per function. Advanced
semiconductor processing technologies increasingly allow semiconductor
manufacturers to produce ICs with smaller features, thereby increasing
processing speed and expanding device functionality and memory capacity. As
ICs
have become more complex, however, both the number and price of state of the
art
process tools required to manufacture ICs have increased significantly. As
a
result, the cost of semiconductor manufacturing equipment has become an
increasingly large part of the total cost of producing advanced ICs.
To
create
an IC, semiconductor wafers are subjected to a large number of complex process
steps. The three primary steps in manufacturing ICs are (1) deposition, in
which
a layer of insulating or conducting material is deposited on the wafer surface,
(2) photolithography, in which the circuit pattern is projected onto a light
sensitive material (the photoresist), and (3) etch, in which the unmasked parts
of the deposited material on the wafer are selectively removed to form the
IC
circuit pattern.
Each
step
of the manufacturing process for ICs requires specialized manufacturing
equipment. Today, plasma-based systems are used for the great majority of both
deposition and etching processes. During physical vapor deposition (also known
as “PVD”), the semiconductor wafer is exposed to a plasma environment that forms
continuous thin films of electrically insulating or electrically conductive
layers on the semiconductor wafer. During a plasma etch process (also known
as
“dry etch”), a semiconductor wafer is exposed to a plasma composed of a reactive
gas, such as chlorine, which etches away selected portions of the layer
underlying the patterned photoresist layer.
Business
Strategy
Our
business objective is to utilize the unique technologies that we have developed
internally or acquired externally in order to increase our market share in
process equipment for both semiconductor manufacturing and nanotechnology device
fabrication. The following are key elements of our strategy:
Maintain
our Technology Leadership Position in New Materials Etch
- We
have become a leading provider of etch process solutions for a set of new
materials central to the production of an array of advanced semiconductor and
nanotechnology devices in emerging markets. Incorporation of these new materials
is essential to achieving the higher device densities, lower power consumption
and novel functions exhibited by the newest generation of cell phones, computer
memories, fiber optic switches and remote sensors. Currently, we are the leading
supplier of etch solutions to makers of advanced “non-volatile” ferro-electric
(“FeRAM”), magnetic (“MRAM”) devices, and virtually all other types of
non-volatile memories. FeRAM is just now entering commercial production with
chips for the newest generation of cell phones, PDA’s, smart cards and RFIDs,
used for applications such as railway passes and ink jet cartridge tracking.
Our
new materials expertise also includes the etching of so-called “compound-semi”
materials, such as GaAs, GaN and InP, widely used in telecom device production.
In addition, we are known for our capability to etch certain noble metals,
such
as gold and platinum, as well as certain proprietary compound metals. This
capability is increasingly important in advanced memory development and in
the
production of Micro-Electrical Mechanical Systems (“MEMS”), a type of
commercially produced nanotechnology device, especially useful to the automotive
industry.
Strengthen
our Position in Deposition Process Equipment for Advanced Packaging Applications
--
Since
2002, we have completed two acquisitions of deposition products incorporating
the same unique “sputter-up” technology. This technology is directed principally
at so-called “back-end” semiconductor manufacturing processes, including
backside metallization and underbump metal processes, for both 200-mm and 300-mm
wafer sizes. These processes are important to advanced, wafer-level packaging
schemes, which are increasingly being used for high-pin-count logic and memory
devices.
Introduce
a New Product into Established Equipment Market --
The
continued development of our recently acquired NLD technology represents our
belief that we have a compelling solution to a critical process need in
present-day and future semiconductor device fabrication. As device geometries
continue to shrink, conventional chemical vapor deposition (“CVD”) process
equipment is increasingly incapable of depositing thin conformal films in
high-aspect ratio trenches and vias. Atomic Level Deposition (“ALD”) is one
technology for satisfying this deposition requirement. However, ALD has several
shortcomings, including low throughput and limitations on film type and quality,
which we believe our NLD technology overcomes.
13
Maintain
our Service Leadership Position
-- Tegal
has been consistently recognized by our customers for providing a high level
of
customer support, a fact that has been noted by our top rankings for several
consecutive years in the annual survey conducted by VLSI Research, Inc. We
expect to maintain and build on this reputation as we seek new customers in
both
emerging and established markets.
Critical
Accounting Policies
Our
discussion and analysis of the financial condition and results of operations
are
based upon our consolidated financial statements, which have been prepared
in
accordance with accounting principles generally accepted in the United States
of
America. The preparation of these financial statements requires us to make
estimates and judgments that affect the reported amounts of assets, liabilities,
revenues and expenses, and related disclosure of contingent assets and
liabilities. On an on-going basis, we evaluate our estimates, including those
related to inventory, warranty obligations, purchase order commitments, bad
debts, income taxes, intangible assets, restructuring and contingencies and
litigation. We base our estimates on historical experience and on various other
assumptions that we believe to be reasonable under the circumstances, the
results of which form the basis for making judgments about the carrying values
of assets and liabilities that are not readily apparent from other sources.
Actual results may differ from these estimates under different assumptions
or
conditions.
We
believe the following critical accounting policies affect our more significant
judgments and estimates used in the preparation of our consolidated financial
statements:
Accounting
for Stock-Based Compensation
Prior
to
April 1, 2006, we accounted for stock-based employee compensation plans under
the measurement and recognition provisions of Accounting Priniciples Board
Opinion No.25, “Accounting for Stock Issued to Employees,” or APB25, and related
Interpretations, as permitted by SFAS No.123, “Accounting for Stock-Based
Compensation”, or SFAS No.123. With the exception of cerain warrants granted and
grants of restricted stock awards, we generally, recorded no stock-based
compensation expenses during periods prior to April 1, 2006 as all stock-based
grants had exercise prices equal to the fair market value of our common stock
on
the date of grant. We also recorded no compensation expense in connection with
our employee stock purchase plan as it qualified as a non-compensatory plan
following the guidance provided by APB25. In accordance with SFAS123 and SFAS
148, “Accounting for Stock-Based Compensation - Transition and Disclosure”, we
disclosed our net loss per share as if we had applied the fair value based
method in measuring compensation expense for our stock-based compensation
programs. Under SFAS 123, we elected to calculate our compensation expense
by
applying the Black-Scholes valuation method,
Effective
April 1, 2006, we adopted the fair value recognition provisions of SFAS No.123R,
using the modified prospective transition method. Under that method,
compensation expense that we recognized for the three months ended June 30,
2006
included: (a) compensation expense for all share-based payment granted prior
to
but not yet vested as of April1, 2006, based on the grant date fair value
estimated in accordance with the original provisions of SFAS 123, and (b)
compensation expense for all share-based payments granted on or modified after
April 1, 2006, based on the grant date fair value estimated in accordance with
the provisions of SFAS123R. Compensation expense is recognized only for those
awards that are expected to vest, whereas prior to the adoption of SFAS123R,
we
recognized forfeitures as they occurred. In addition, we elected the
straight-line attribution method as our accounting policy for recognizing
stock-based compensation expense for all awards granted.
We
estimate the fair value of options granted using the Black Scholes option
valuation and the assumptions shown in Note.1 to our condensed consolidated
financial statements. All options are amortized over the requisite service
periods of the awards, which are generally the vesting periods.
Revenue
Recognition
Each
sale
of our equipment is evaluated on an individual basis in regard to revenue
recognition. We have integrated in our evaluation the related interpretative
guidance included in Topic 13 of the codification of staff accounting bulletins,
and recognize the role of the FASB’s Emerging Issues Task Force (“EITF”)
consensus on Issue 00-21. We first refer to EITF 00-21 in order to determine
if
there is more than one unit of accounting and then we refer to SAB104 for
revenue recognition topics for the unit of accounting. We recognize revenue
when
persuasive evidence of an arrangement exists, the seller’s price is fixed or
determinable and collectibility is reasonably assured.
For
products produced according to our published specifications, where no
installation is required or installation is deemed perfunctory and no
substantive customer acceptance provisions exist, revenue is recognized when
title passes to the customer, generally upon shipment. Installation is not
deemed to be essential to the functionality of the equipment since installation
does not involve significant changes to the features or capabilities of the
equipment or building complex interfaces and connections. In addition, the
equipment could be installed by the customer or other vendors and generally
the
cost of installation approximates only 1% of the sales value of the related
equipment.
14
For
products produced according to a particular customer’s specifications, revenue
is recognized when the product has been tested and it has been demonstrated
that
it meets the customer’s specifications and title passes to the customer. The
amount of revenue recorded is reduced by the amount (generally 10%), which
is
not payable by the customer until installation is completed and final customer
acceptance is achieved.
For
new
products, new applications of existing products, or for products with
substantive customer acceptance provisions where performance cannot be fully
assessed prior to meeting customer specifications at the customer site, 100%
of
revenue is recognized upon completion of installation and receipt of final
customer acceptance. Since title to goods generally passes to the customer
upon
shipment and 90% of the contract amount becomes payable at that time, inventory
is relieved and accounts receivable is recorded for the entire contract amount.
The revenue on these transactions is deferred and recorded as deferred revenue.
We reserve for warranty costs at the time the related revenue is
recognized.
Revenue
related to sales of spare parts is recognized upon shipment. Revenue related
to
maintenance and service contracts is recognized ratably over the duration of
the
contracts. Unearned maintenance and service revenue is included in other accrued
liabilities.
Accounts
Receivable - Allowance for Sales Returns and Doubtful
Accounts
We
maintain an allowance for doubtful accounts receivable for estimated losses
resulting from the inability of our customers to make required payments. If
the
financial conditions of our customers were to deteriorate, or even a single
customer was otherwise unable to make payments, additional allowances may be
required.
Our
return policy is for spare parts and components only. Customers are allowed
to
return spare parts if they are defective upon receipt, in accordance with SFAS
48. The potential returns are offset against gross revenue on a monthly basis.
Management reviews outstanding requests for returns on a quarterly basis to
determine that the reserves are adequate.
Inventories
Inventories
are stated at the lower of cost or market, reduced by provisions for excess
and
obsolescence. Cost is computed using standard cost, which approximates actual
cost on a first-in, first-out basis and includes material, labor and
manufacturing overhead costs. We estimate the effects of excess and obsolescence
on the carrying values of our inventories based upon estimates of future demand
and market conditions. We establish provisions for related inventories in excess
of production demand. Should actual production demand differ from our estimates,
additional inventory write-downs may be required, as was the case in the current
quarter and the
fourth quarter of fiscal 2005. Any excess and obsolete provision is released
only if and when the related inventories is sold or scrapped. The inventory
provision balance at June 30, 2006 and March 31, 2006 was $5,047 and $7,136,
respectively. The inventory provision expense for the period ended June 30,
2006
and March 31, 2006 was $(2,088)
and $(1,146),
respectively.
We
periodically analyze any systems that are in finished goods inventory to
determine if they are suitable for current customer requirements. At the present
time, our policy is that if after approximately 18 months we determine that
a
sale will not take place within the next 12 months, and the system would be
useable for customer demonstrations or training, it is transferred to fixed
assets. Otherwise, it is expensed.
The
carrying value of systems used for demonstrations or training is determined
by
assessing the cost of the components that are suitable for sale. Any parts
that
may be rendered not saleable as a result of such use are removed from the system
and are not included in finished goods inventory. The remaining saleable parts
are valued at the lower of cost or market, representing the system’s net
realizable value. The depreciation period for systems that are transferred
to
fixed assets is determined based on the age of the system and its remaining
useful life (typically five to eight years).
15
Impairment
of Long-Lived Assets
Long-lived
assets are reviewed for impairment whenever events or changes in circumstances
indicate that the carrying amount may not be recoverable. If undiscounted
expected future cash flows are less than the carrying value of the assets,
an
impairment loss is recognized based on the excess of the carrying amount over
the fair value of the assets.
Warranty
Obligations
We
provide for the estimated cost of our product warranties at the time revenue
is
recognized. Our warranty obligation is affected by product failure rates,
material usage rates and the efficiency by which the product failure is
corrected. Should actual product failure rates, material usage rates and labor
efficiencies differ from our estimates, revisions to the estimated warranty
liability may be required.
Deferred
Taxes
We
record
a valuation allowance to reduce our deferred tax assets to the amount that
is
more likely than not to be realized. Based on the uncertainty of future taxable
income, we have fully reserved our deferred tax assets. In the event we were
to
determine that we would be able to realize our deferred tax assets in the
future, an adjustment to the deferred tax asset would increase income in the
period such determination was made.
Results
of Operations
The
following table sets forth certain financial items as a percentage of revenue
for the three months ended June 30, 2006 and 2005:
|
Three
Months Ended
June
30,
|
||||||
|
2006
|
2005
|
|||||
Revenue
|
100.0
|
%
|
100.0
|
%
|
|||
Cost
of sales
|
62.0
|
%
|
77.9
|
%
|
|||
Gross
profit
|
38.0
|
%
|
22.1
|
%
|
|||
Operating
expenses:
|
|||||||
Research
and development
|
15.1
|
%
|
38.5
|
%
|
|||
Sales
and marketing
|
15.9
|
%
|
21.1
|
%
|
|||
General
and administrative
|
35.0
|
%
|
40.6
|
%
|
|||
Total
operating expenses
|
66.0
|
%
|
100.2
|
%
|
|||
Other
Expense (Income)
|
.6
|
%
|
(4.0
|
)%
|
|||
Net
loss
|
(27.4)
|
%
|
(82.1
|
)%
|
The
following table sets forth certain financial items for the three month periods
ended June 30, 2006 and 2005:
|
Three
Months
Ended
June
30
|
||||||
|
2006
|
2005
|
|||||
Revenue
|
$
|
6,576
|
$
|
3,052
|
|||
Cost
of sales
|
4,078
|
2,377
|
|||||
Gross
profit
|
$
|
2,498
|
$
|
675
|
|||
Operating
expenses:
|
|||||||
Research
and development
|
996
|
1,176
|
|||||
Sales
and marketing
|
1,044
|
644
|
|||||
General
and administrative
|
2,302
|
1,240
|
|||||
Total
operating expenses
|
4,342
|
3,060
|
|||||
Other
Expense (Income)
|
42
|
(122
|
)
|
||||
Net
loss
|
$
|
(1,802
|
)
|
$
|
(2,507
|
)
|
16
Revenue
The
increase in revenue for the three months ended June 30, 2006 was principally
due
to the sale of three additional etch series systems and two advanced systems
over the same period of the previous year.
International
sales as a percentage of the Company’s revenue for the three
months
ended
June 30, 2006 were approximately 23.3%, and for the three months ended June
30,
2005 were approximately 89.0%. We believe that international sales will continue
to represent a significant portion of our revenue.
Gross
profit (loss)
Gross
profit as a percentage to revenue for the three months ended June 30, 2006
increased by $1,823 to
38.0%
which is a 15.9% percentage point increase over the 22.1% of the three periods
ended June 30, 2005.
The
increase in gross profit as a percentage to revenue, was principally
attributable an
increase in system sales.
System
sales generally have higher gross margins than the sale of spares and
service.
Research
and Development
Research
and development expenses consist primarily of salaries, prototype material
and
other costs associated with our ongoing systems and process technology
development, applications and field process support efforts. The decrease in
research and development spending for the three months ended June 30, 2006
resulted from lower license fees, consulting, employee travel, and recruiting
expenses as compared to the prior year.
Sales
and Marketing
Sales
and
marketing expenses consist primarily of salaries, commissions, trade show
promotion and travel and living expenses associated with those functions. The
increase in sales and marketing spending for the three months ended June 30,
2006 was primarily due to
$289
higher commissions over the same period last year combined with increased
spending on trade shows. If revenue continues to increase period over period,
commission expense will also increase.
General
and Administrative
General
and administrative expenses consist primarily of compensation for general
management, accounting and finance, human resources, information systems and
investor relations functions and for legal, consulting and accounting fees
of
the Company. The increase in spending for the three months ended June 30, 2006
was primarily due to increases in accounting fees, stock compensation expense,
and legal fees. The increase in legal fees is primarily due to the litigation
against AMS, Agilent, and Avago Technologies. The trial is due to be completed
by the end of December 2006, at which time, legal fees will be
reduced.
Other
income (expense), net
Other
income (expense), net consists principally of, interest income, interest
expense, other income, (expense), gains and losses on the disposal of fixed
assets, and gains and losses on foreign exchange. We recorded net non-operating
income of $42 and non-operating loss of $122 during the three-month period
ending June 30, 2006 respectively.
17
Contractual
obligation
The
following summarizes our contractual obligations at June 30, 2006, and the
effect such obligations are expected to have on our liquidity and cash flows
in
future periods.
Contractual
obligations:
|
Total
|
Less
than
1
Year
|
1-3
Years
|
3-5
Years
|
After
5
Years
|
|||||||||||
Non-cancelable
capital lease obligations
|
$
|
11
|
$
|
11
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||
Non-cancelable
operating lease obligations
|
1,558
|
1002
|
433
|
123
|
—
|
|||||||||||
Notes
payable and bank lines of credit
|
107
|
107
|
—
|
—
|
—
|
|||||||||||
Total
contractual cash obligations
|
$
|
1
,676
|
$
|
1,120
|
$
|
433
|
$
|
123
|
$
|
—
|
Certain
sales contracts of the Company include provisions under which customers would
be
indemnified by the Company in the event of, among other things, a third-party
claim against the customer for intellectual property rights infringement related
to the Company's products. There are no limitations on the maximum potential
future payments under these indemnities. The Company has accrued no amounts
in
relation to these provisions as no such claims have been made and the Company
believes it has valid, enforceable rights to the intellectual property embedded
in its products.
Liquidity
and Capital Resources
For
the
three-month period ended June 30, 2006, we financed our operations through
the
use of outstanding cash balances, borrowings against our credit facilities
in
Japan and net proceeds from the 2005 PIPE.
As
of
June 30, 2006, our Japanese subsidiary had $107 outstanding under its lines
of
credit which is collateralized by Japanese customer promissory notes held by
such subsidiary in advance of payment on customers’ accounts receivable. The two
credit lines have a total borrowing capacity of 150 million yen (approximately
$1,304 at exchange rates prevailing on June 30, 2006), which are secured by
Japanese customer promissory notes held by such subsidiary in advance of payment
on customers’ accounts receivable. The two Japanese bank lines bear interest at
Japanese prime (1.375% as of June 30, 2006) plus 0.875%.
Notes
payable as of June 30, 2006 consisted of capital lease obligations on fixed
assets totaling $11.
The
consolidated financial statements contemplate the realization of assets and
the
satisfaction of liabilities in the normal course of business. We incurred net
losses of $1,802 and $2,507 for the three months ended June 30, 2006 and 2005,
respectively. We generated negative cash flows from operations of $1,322 and
$3,832 for the period ended June 30, 2006 and June 30, 2005, respectively.
During the prior fiscal year 2006, we raised a net of $18,161 through the 2005
PIPE. Management believes that these proceeds, combined with projected sales,
consolidation of certain operations and continued cost containment will be
adequate to fund operations through fiscal 2007. However, projected sales may
not materialize and unforeseen costs may be incurred.
If
the
projected sales do not materialize, our ability to achieve our intended business
objectives may be adversely affected. The consolidated financial statements
do
not include any adjustments relating to the recoverability and classification
of
recorded assets or the amount or classification of liabilities or any other
adjustments that might be necessary should we be unable to continue as a going
concern.
Item
3. Quantitative
and Qualitative Disclosures About Market Risk
Our
cash
equivalents are principally comprised of money market accounts. As of
March
31,
2006,
we had
cash and cash equivalents of $12,640.
These
accounts are subject to interest rate risk and may fall in value if market
interest rates increase. We attempt to limit this exposure by investing
primarily in short-term securities having a maturity of three months or less.
Due to the nature of our cash and cash equivalents, we have concluded that
there
is no material market risk exposure.
We
have
foreign subsidiaries that operate and sell our products in various global
markets. As a result, our cash flow and earnings are exposed to fluctuations
in
interest and foreign currency exchange rates. We attempt to limit these
exposures through the use of various hedge instruments, primarily forward
exchange contracts and currency option contracts (with maturities of less than
three months) to manage our exposure associated with firm commitments and net
asset and liability positions denominated in non-functional currencies. There
have been no material changes regarding market risk since the disclosures made
in our Form 10-K for the fiscal year ended March 31, 2006.
18
At
June
30, 2006, the Company had forward exchange contracts maturing at various dates
to exchange 300,658
yen into $2.7 million.
Item
4. Controls
and Procedures
We
maintain disclosure controls and procedures that are designed to ensure that
information required to be disclosed in our Exchange Act reports is recorded,
processed, summarized and reported within the time periods specified in the
SEC’s rules and forms, and that such information is accumulated and communicated
to our management, including our Chief Executive Officer and Chief Financial
Officer, as appropriate, to allow for timely decisions regarding required
disclosure. In designing and evaluating our disclosure controls and procedures,
our management recognizes that any controls and procedures, no matter how well
designed and operated, can provide only reasonable assurance of achieving the
desired control objectives, and our management is required to apply its judgment
in evaluating the cost-benefit relationship of possible controls and procedures.
(a) Evaluation
of Disclosure Controls and Procedures. Based
on
their evaluation as of a date at the end of the quarter covered by this
quarterly report on Form 10-Q, the Company’s Chief Executive Officer and Chief
Financial Officer have concluded that the Company’s disclosure controls and
procedures (as defined in Rules 13a-14(c) under the Securities Exchange Act
of
1934) are effective at the reasonable assurance level.
(b) Changes
in Internal Controls.
There
has been no change in the Company’s internal control over financial reporting
during the fiscal quarter ended June 30, 2006 that has materially affected,
or
is reasonably likely to materially affect, the Company’s internal controls over
financial reporting
PART
II — OTHER INFORMATION
Item
1. Legal
Proceedings
Sputtered
Films, Inc. v. Advanced Modular Sputtering, et al., filed in Santa Barbara
County Superior Court.
On
December 22, 2003, Sputtered Films, Inc. ("SFI"), a wholly owned subsidiary
of
the Company, filed an action against two former employees, Sergey Mishin and
Rose Stuart-Curran, and a company they formed after leaving their employment
with SFI named Advanced Modular Sputtering, Inc. ("AMS"). Sergey Mishin and
Rose
Stuart-Curran had each signed confidentiality and non-disclosure agreements
regarding information obtained while employed by SFI. The action contains causes
of action for specific performance, breach of contract, breach of the covenant
of good faith and fair dealing, misappropriation of trade secrets, unfair
competition, unfair business practices, and interference with prospective
economic advantage, conversion, unjust enrichment, and declaratory relief.
These
claims arise out of information SFI received evidencing that AMS possessed
and
used SFI's confidential, proprietary and trade secret drawings, specifications
and technology to manufacture the sputtering tool marketed by AMS.
During
2004 and 2005, this litigation was largely stalled while AMS and Agilent
Technologies, Inc. contested SFI's right to conduct discovery. This dispute
was
resolved in late 2005 when the California Court of Appeal affirmed SFI's trade
secret identification as statutorily sufficient. On November 18, 2005, SFI
requested leave to add Agilent Technologies, Inc. ("Agilent") as a defendant
based on evidence that Agilent and AMS co-developed the machines which SFI
contends were built using SFI proprietary information. The Court granted SFI's
request and Agilent was served as a Doe defendant on December 12, 2005. In
early
December, SFI learned that Agilent transferred its Semiconductor Products Group
to a number of Avago entities effective December 1, 2005, and accordingly SFI
sought and received court approval to add Avago Technologies U.S., Inc. and
Avago Technologies Wireless (U.S.A.) Manufacturing, Inc (collectively the "Avago
Entities") as defendant in this action. On April 25, 2006, the Avago Entities
filed a Cross-Complaint against SFI and Tegal Corporation alleging causes of
action for breach of contract, trade secret misappropriation, unfair
competition, conversion, unjust enrichment and declaratory relief. The
Cross-Complaint alleges on information and belief that SFI misused information
obtained from Hewlett-Packard in connection with Hewlett-Packard's request
to
purchase SFI machines or to upgrade SFI machines Hewlett-Packard already owned.
SFI and Tegal Corporation intend to vigorously contest all such allegations.
Trial is currently set for November 7, 2006, although the Court has indicated
that it may bifurcate the Avago Entities' cross-claims. The Court severed from
SFI's action the Cross-Complaint filed by the Avago Entities, and all matters
regarding the Avago Cross-Complaint, including discovery, are stayed until
after
completion of the trial on SFI's Complaint.
19
Item
1A. Risk
Factors
We
wish to caution you that there are risks and uncertainties that could affect
our
business. These risks and uncertainties include, but are not limited to, the
risks described below and elsewhere in this report, particularly in
“Forward-Looking Statements.” The following is not intended to be a complete
discussion of all potential risks or uncertainties, as it is not possible to
predict or identify all risk factors. The risk factors set forth below are
also
set forth in Part 1, Item 1A of our Annual Report on Form 10-K for the fiscal
year ended March 31, 2006. Except for the deletion of the risk factor
entitled "If we fail to meet the continued listing requirements of the Nasdaq
Stock Market, our stock could be delisted," there have been no material changes
made.
We
have incurred operating losses and may not be profitable in the future; our
plans to maintain and increase liquidity may not be successful.
We
incurred net losses of $8.9 million; $15.4 million and $12.6 million for the
years ended March 31, 2006, 2005 and 2004, respectively, and generated negative
cash flows from operations of $11.7 million, $7.5 million and $3.2 million
in
these respective years. We have raised approximately $18.4 million from the
sale
of stock and warrants to institutional investors in fiscal year 2006. Management
believes that these proceeds, combined with a projected increase in sales,
consolidation of certain operations and continued cost containment will be
adequate to fund operations through Fiscal Year 2007. If the projected sales
do
not materialize, we will need to reduce expenses further and raise additional
capital through the issuance of debt or equity securities. If additional funds
are raised through the issuance of preferred stock or debt, these securities
could have rights, privileges or preferences senior to those of our common
stock, and debt covenants could impose restrictions on our operations. Moreover,
such financing may not be available to us on acceptable terms, if at all.
Failure to raise additional funds may adversely affect our ability to achieve
our intended business objectives.
The
exercise of outstanding warrants, options and other rights to obtain additional
shares will dilute the value of our shares of common stock and could cause
the
price of our shares of common stock to decline.
As
of
June 30, 2006, there were
7,039,173 shares
of
our common stock issued and outstanding and there were
2,040,675 shares
of
common stock reserved for issuance under our equity incentive and stock purchase
plans.
As
of
June 30, 2006, there were warrants, stock options and restricted stock awards
outstanding for approximately 2,342,817
shares
of our common stock on a post reverse split basis.
The
exercise of these warrants and options and the issuance of the common stock
pursuant to our equity incentive plans will result in dilution in the value
of
the shares of our outstanding common stock and the voting power represented
thereby. In addition, the exercise price of the warrants may be lowered under
the price adjustment provisions in the event of a “dilutive issuance,” that is,
if we issue common stock at any time prior to their maturity at a per share
price below such conversion or exercise price, either directly or in connection
with the issuance of securities that are convertible into, or exercisable for,
shares of our common stock. A reduction in the exercise price may result in
the
issuance of a significant number of additional shares upon the exercise of
the
warrants.
The
warrants do not establish a “floor” that would limit reductions in such
conversion price or exercise price. The downward adjustment of the exercise
price of these warrants could result in further dilution in the value of the
shares of our outstanding common stock and the voting power represented
thereby.
No
prediction can be made as to the effect, if any, that future sales of shares
of
our common stock, or the availability of shares for future sale, will have
on
the market price of our common stock prevailing from time to time. Sales of
substantial amounts of shares of our common stock in the public market, or
the
perception that such sales could occur, may adversely affect the market price
of
our common stock and may make it more difficult for us to sell our equity
securities in the future at a time and price which we deem appropriate.
To
the
extent our stockholders and the other holders of our warrants and options
exercise such securities and then sell the shares of our common stock they
receive upon exercise, our stock price may decrease due to the additional amount
of shares available in the market. The subsequent sales of these shares could
encourage short sales by our security holders and others, which could place
further downward pressure on our stock price. Moreover, holders of these
warrants and options may hedge their positions in our common stock by shorting
our common stock, which could further adversely affect our stock
price.
20
The
semiconductor industry is cyclical and may experience periodic downturns that
may negatively affect customer demand for our products and result in losses
such
as those experienced in the past.
Our
business depends upon the capital expenditures of semiconductor manufacturers,
which in turn depend on the current and anticipated market demand for integrated
circuits. The semiconductor industry is highly cyclical and historically has
experienced periodic downturns, which often have had a detrimental effect on
the
semiconductor industry’s demand for semiconductor capital equipment, including
etch and deposition systems manufactured by us. Despite a moderate recovery
in
the industry, we have continued to implement a cost containment program and
have
completed a corporate-wide restructuring to preserve our cash. However, the
need
for continued investment in research and development, possible capital equipment
requirements and extensive ongoing customer service and support requirements
worldwide will continue to limit our ability to reduce expenses in response
to
any future downturns. As a result, we may continue to experience operating
losses such as those we have experienced in the past, which could materially
adversely affect us.
Our
competitors have greater financial resources and greater name recognition than
we do and therefore may compete more successfully in the semiconductor capital
equipment industry than we can.
We
believe that to be competitive, we will require significant financial resources
in order to offer a broad range of systems, to maintain customer service and
support centers worldwide and to invest in research and development. Many of
our
existing and potential competitors, including, among others, Applied Materials,
Inc., Lam Research Corporation, Novellus and Tokyo Electron Limited, have
substantially greater financial resources, more extensive engineering,
manufacturing, marketing and customer service and support capabilities, larger
installed bases of current generation etch, deposition and other production
equipment and broader process equipment offerings, as well as greater name
recognition than we do. We cannot assure you that we will be able to compete
successfully against these companies in the United States or
worldwide.
Our
potential customers may not adopt our products because of their significant
cost
or because our potential customers are already using a competitor’s tool.
A
substantial investment is required to install and integrate capital equipment
into a semiconductor production line. Additionally, we believe that once a
device manufacturer has selected a particular vendor’s capital equipment, that
manufacturer generally relies upon that vendor’s equipment for that specific
production line application and, to the extent possible, subsequent generations
of that vendor’s systems. Accordingly, it may be extremely difficult to achieve
significant sales to a particular customer once that customer has selected
another vendor’s capital equipment unless there are compelling reasons to do so,
such as significant performance or cost advantages. Any failure to gain access
and achieve sales to new customers will adversely affect the successful
commercial adoption of our products and could have a detrimental effect on
us.
We
depend on sales of our advanced products to customers that may not fully adopt
our product for production use.
We
have
designed our advanced etch and deposition products for customer applications
in
emerging new films, polysilicon and metal which we believe to be the leading
edge of critical applications for the production of advanced semiconductor
and
other microelectronic devices. Revenues from the sale of our advanced etch
and
deposition systems accounted for 69%, 30% and 40% of total revenues in fiscal
2006, 2005 and 2004, respectively. Our advanced systems are currently being
used
primarily for research and development activities or low volume production.
For
our advanced systems to achieve full market adoption, our customers must utilize
these systems for volume production. We cannot assure you that the market for
devices incorporating emerging films, polysilicon or metal will develop as
quickly or to the degree we expect. If our advanced systems do not achieve
significant sales or volume production due to a lack of customer adoption,
our
business, financial condition, results of operations and cash flows will be
materially adversely affected.
Our
customers are concentrated and therefore the loss of a significant customer
may
harm our business.
The
composition of our top five customers has changed from year to year, but net
system sales to our top five customers in each of fiscal 2006, 2005, and 2004
accounted for 68.9%, 80.0% and 84.8%, respectively, of our total net system
sales. ST Microelectronics accounted for 54.3% of our total revenue in fiscal
2006. Fujitsu, Western Digital, and RF Micro Devices accounted for 38.2%, 12.8%
and 10.1% respectively, of our net system sales in fiscal year 2005. Intel,
Fuji
Film, and Matsushita accounted for 31.4%, 22.9% and 12.6% respectively, of
our
net system sales in 2004. ST Microelectronics accounted for 47% of total revenue
in the quarter ended June 30, 2006. Other than these customers, no single
customer represented more than 10% of our total revenue in fiscal 2006, 2005,
and 2004. Although the composition of the group comprising our largest customers
may vary from year to year, the loss of a significant customer or any reduction
in orders by any significant customer, including reductions due to market,
economic or competitive conditions in the semiconductor and related device
manufacturing industry, may have a material adverse effect on us.
21
Our
quarterly operating results may continue to fluctuate.
Our
revenue and operating results have fluctuated and are likely to continue to
fluctuate significantly from quarter to quarter, and we cannot assure you that
we will achieve profitability in the future.
Our
900
series etch systems typically sell for prices ranging between $250,000 and
$600,000, while prices of our 6500 series critical etch systems and our Endeavor
deposition system typically range between $1,500,000
and
$3,000,000. To the extent we are successful in selling our 6500 and Endeavor
series systems, the sale of a small number of these systems will probably
account for a substantial portion of revenue in future quarters, and a
transaction for a single system could have a substantial impact on revenue
and
gross margin for a given quarter.
Other
factors that could affect our quarterly operating results include:
· |
our
timing of new systems and technology announcements and releases and
ability to transition between product
versions;
|
· |
seasonal
fluctuations in sales;
|
· |
changes
in the mix of our revenues represented by our various products and
customers;
|
· |
adverse
changes in the level of economic activity in the United States or
other
major economies in which we do
business;
|
· |
foreign
currency exchange rate
fluctuations;
|
· |
expenses
related to, and the financial impact of, possible acquisitions of
other
businesses; and
|
· |
changes
in the timing of product orders due to unexpected delays in the
introduction of our customers’ products, due to lifecycles of our
customers’ products ending earlier than expected or due to market
acceptance of our customers’
products.
|
Some
of our sales cycles are lengthy, exposing us to the risks of inventory
obsolescence and fluctuations in operating results.
Sales
of
our systems depend, in significant part, upon the decision of a prospective
customer to add new manufacturing capacity or to expand existing manufacturing
capacity, both of which typically involve a significant capital commitment.
We
often experience delays in finalizing system sales following initial system
qualification while the customer evaluates and receives approvals for the
purchase of our systems and completes a new or expanded facility. Due to these
and other factors, our systems typically have a lengthy sales cycle (often
12 to
18 months in the case of critical etch and deposition systems) during which
we
may expend substantial funds and management effort. Lengthy sales cycles subject
us to a number of significant risks, including inventory obsolescence and
fluctuations in operating results over which we have little or no
control.
Because
technology changes rapidly, we may not be able to introduce our products in
a
timely manner.
The
semiconductor manufacturing industry is subject to rapid technological change
and new system introductions and enhancements. We believe that our future
success depends on our ability to continue to enhance our existing systems
and
their process capabilities, and to develop and manufacture in a timely manner
new systems with improved process capabilities. We may incur substantial
unanticipated costs to ensure product functionality and reliability early in
our
products’ life cycles. We cannot assure you that we will be successful in the
introduction and volume manufacture of new systems or that we will be able
to
develop and introduce, in a timely manner, new systems or enhancements to our
existing systems and processes which satisfy customer needs or achieve market
adoption.
22
Our
financial performance may adversely affect the morale and performance of our
personnel and our ability to hire new personnel.
Our
common stock has declined in value below the exercise price of many options
granted to employees pursuant to our stock option plans. Thus, the intended
benefits of the stock options granted to our employees, the creation of
performance and retention incentives, may not be realized. As a result, we
may
lose employees whom we would prefer to retain. As a result of these factors,
our
remaining personnel may seek employment with larger, more established companies
or companies perceived as having less volatile stock prices.
We
may not be able to protect our intellectual property or obtain licenses for
third parties’ intellectual property and therefore we may be exposed to
liability for infringement or the risk that our operations may be adversely
affected.
Although
we attempt to protect our intellectual property rights through patents,
copyrights, trade secrets and other measures, we may not be able to protect
our
technology adequately and competitors may be able to develop similar technology
independently. Additionally, patent applications that we may file may not be
issued and foreign intellectual property laws may not protect our intellectual
property rights. There is also a risk that patents licensed by or issued to
us
will be challenged, invalidated or circumvented and that the rights granted
there under will not provide competitive advantages to us. Furthermore, others
may independently develop similar systems, duplicate our systems or design
around the patents licensed by or issued to us.
Litigation
could result in substantial cost and diversion of effort by us, which by itself
could have a detrimental effect on our financial condition, operating results
and cash flows. Further, adverse determinations in such litigation could result
in our loss of proprietary rights, subject us to significant liabilities to
third parties, require us to seek licenses from third parties or prevent us
from
manufacturing or selling our systems. In addition, licenses under third parties’
intellectual property rights may not be available on reasonable terms, if at
all.
We
are exposed to additional risks associated with international sales and
operations.
International
sales accounted for 76%, 70% and 67% of total revenue for fiscal 2006, 2005
and
2004, respectively. International sales are subject to certain risks, including
the imposition of government controls, fluctuations in the U.S. dollar (which
could increase the sales price in local currencies of our systems in foreign
markets), changes in export license and other regulatory requirements, tariffs
and other market barriers, political and economic instability, potential
hostilities, restrictions on the export or import of technology, difficulties
in
accounts receivable collection, difficulties in managing representatives,
difficulties in staffing and managing international operations and potentially
adverse tax consequences. We cannot assure you that any of these factors will
not have a detrimental effect on our operations, financial results and cash
flows.
We
generally attempt to offset a portion of our U.S. dollar denominated balance
sheet exposures subject to foreign exchange rate re-measurement by purchasing
forward currency contracts for future delivery. We cannot assure you that our
future results of operations and cash flows will not be adversely affected
by
foreign currency fluctuations. In addition, the laws of certain countries in
which our products are sold may not provide our products and intellectual
property rights with the same degree of protection as the laws of the United
States.
Evolving
regulation of corporate governance and public disclosure may result in
additional expenses and continuing uncertainty.
Changing
laws, regulations and standard relating to corporate governance and public
disclosure, including the Sarbanes-Oxley Act of 2002, new SEC regulations and
Nasdaq Market rules are creating uncertainty for public companies. We
continually evaluate and monitor developments with respect to new and proposed
rules and cannot predict or estimate the amount of the additional costs we
may
incur or the timing of such costs. These new or changed laws, regulations and
standards are subject to varying interpretations, in many cases due to their
lack of specificity, and as a result, their application in practice may evolve
over time as new guidance is provided by regulatory and governing bodies. This
could result in continuing uncertainty regarding compliance matters and higher
costs necessitated by ongoing revisions to disclosure and governance practices.
We are committed to maintaining high standards of corporate governance and
public disclosure. As a result, we have invested resources to comply with
evolving laws, regulations and standards, and this investment may result in
increased general and administrative expenses and a diversion of management
time
and attention from revenue-generating activities to compliance activities.
If
our efforts to comply with new or changed laws, regulations and standards differ
from the activities intended by regulatory or governing bodies due to
ambiguities related to practice, regulatory authorities may initiate legal
proceedings against us and we may be harmed.
23
Our
stock price is volatile and could result in a material decline in the value
of
your investment in Tegal.
We
believe that factors such as announcements of developments related to our
business, fluctuations in our operating results, sales of our common stock
into
the marketplace, failure to meet or changes in analysts’ expectations, general
conditions in the semiconductor industry or the worldwide economy, announcements
of technological innovations or new products or enhancements by us or our
competitors, developments in patents or other intellectual property rights,
developments in our relationships with our customers and suppliers, natural
disasters and outbreaks of hostilities could cause the price of our common
stock
to fluctuate substantially. In addition, in recent years the stock market in
general, and the market for shares of small capitalization stocks in particular,
have experienced extreme price fluctuations, which have often been unrelated
to
the operating performance of affected companies. We cannot assure you that
the
market price of our common stock will not experience significant fluctuations
in
the future, including fluctuations that are unrelated to our
performance.
Potential
disruption of our supply of materials required to build our systems could have
a
negative effect on our operations and damage our customer
relationships.
Materials
delays have not been significant in recent years. Nevertheless, we procure
certain components and sub-assemblies included in our systems from a limited
group of suppliers, and occasionally from a single source supplier. For example,
we depend on MECS Corporation, a robotic equipment supplier, as the sole source
for the robotic arm used in all of our 6500 series systems. We currently have
no
existing supply contract with MECS Corporation, and we currently purchase all
robotic assemblies from MECS Corporation on a purchase order basis. Disruption
or termination of certain of these sources, including our robotic sub-assembly
source, could have an adverse effect on our operations and damage our
relationship with our customers.
Any
failure by us to comply with environmental regulations imposed on us could
subject us to future liabilities.
We
are
subject to a variety of governmental regulations related to the use, storage,
handling, discharge or disposal of toxic, volatile or otherwise hazardous
chemicals used in our manufacturing process. We believe that we are currently
in
compliance in all material respects with these regulations and that we have
obtained all necessary environmental permits generally relating to the discharge
of hazardous wastes to conduct our business. Nevertheless, our failure to comply
with present or future regulations could result in additional or corrective
operating costs, suspension of production, and alteration of our manufacturing
processes or cessation of our operations.
(a) Exhibits
10.1
|
Eighth
Amended and Restated 1998 Equity Participation Plan
|
|
10.2
|
Fifth
Amended and Restated Outside Directors Plan
|
|
31.1
|
Certifications
of the Chief Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
31.2
|
Certifications
of the Chief Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
32
|
Certifications
of the Chief Executive Officer and Chief Financial Officer pursuant
to
Section 906 of the Sarbanes-Oxley Act of
2002.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
TEGAL
CORPORATION
(Registrant)
|
||
Date: August 14 , 2006 | By: | /s/ CHRISTINE HERGENROTHER |
Christine Hergenrother |
||
Chief
Financial Officer
|
24